About Us

Founded in 2017 during the early stages of cannabis legalization, swisscann is now one of the key players shaping the medical cannabis market in Switzerland and Europe. Our headquarters are located in Technopark Zurich, while our state-of-the-art production facility in Glattfelden covers the entire value chain—from cultivation and processing to packaging and distribution.
Our goal is to produce medical cannabis of the highest quality while ensuring a standardized cannabinoid composition. To achieve this, we rely on cutting-edge cultivation technologies and strictly controlled production processes. In addition, with a strong focus on the Swiss and EU markets, we supply pharmacies, hospitals, and pharmaceutical companies with GMP-certified products. Our production meets the highest pharmaceutical standards, and all our products embody Swiss precision, purity, and quality.

cannabis für medizinische produkte

Vision

The medical potential of the cannabis plant is considered to be very high. Active compounds in cannabis are cannabinoids, with over 60 identified to date. Among these, the most well-known cannabinoid is the pharmacologically active tetrahydrocannabinol (THC), which is increasingly used in medicine for patient treatment. Other cannabinoids, such as cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN), also possess various interesting pharmacological properties that are being increasingly studied as part of the legalization process for medical purposes.

At swisscann, we are convinced of the medical efficacy of cannabis. Therefore, our goal is to harness the full potential of the plant and provide patients with high-quality, standardized, and safe cannabis products. With our GMP-certified products, we aim to contribute to effective and evidence-based therapy. Ultimately, our vision is to sustainably improve patients’ quality of life with our products and further advance the medical use of cannabis.

Mission

At swisscann, our goal is to produce medical cannabis of the highest quality and ensure a consistent cannabinoid composition. To achieve this, we rely on a diverse selection of stable plant genetics, controlled high-tech production processes in a cleanroom environment, as well as research and close collaboration with international partners. We pursue our mission with the utmost professionalism and passion to provide patients with safe, effective, and standardized cannabis products.

Our Values

Team

The Executive Team and Board of Directors consist of Jaan Spitz and Daniel Gelemanovic.

Daniel Gelemanovic
Daniel GelemanovicCEO & Co-Founder
Recht, Finanzen & Geschäftsentwicklung
Jurist, MLaw
Jaan Spitz
Jaan SpitzCOO & Co-Founder
Produktion / R&D
Neuroinformatician
Julien Baustert
Julien Baustert
Head of GMP Production
Daniel Kun
Daniel Kun
QM Manager / Quality Assurance
Regula Randegger
Regula RandeggerBSc
Operations & Supply Chain
Brigitta Ebnöther
Brigitta EbnötherMA
HR
Wolfgang Hähnel
Wolfgang Hähnel
GMP Officer & Production
Dr. Michel Sekulic
Dr. Michel Sekulic
Person responsible for narcotics
Clara Leo
Clara Leo
Administrative support

State-of-the-art production methods for high-quality cannabis products

Our Production

Exciting field of work and excellent working conditions

Career with Us